Capital Fund Management S.A. Exact Sciences Corp Put Options Transaction History

Capital Fund Management S.A.

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $428,543 - $715,383	-10,100 Reduced 13.05%	67,300 $4.58 Million
Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $760,472 - $1.37 Million	18,400 Added 31.19%	77,400 $3.27 Million
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $4.79 Million - $6.29 Million	-85,200 Reduced 59.08%	59,000 $4.07 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $5.37 Million - $6.88 Million	90,900 Added 170.54%	144,200 $10.7 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $3.51 Million - $5.28 Million	53,300 New	53,300 $3.64 Million
Q2 2019 Aug 12, 2019	SELL	$89.51 - $118.04 $3.07 Million - $4.05 Million	-34,300 Reduced 82.45%	7,300 $862,000
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $1.4 Million - $2.33 Million	28,900 Added 227.56%	41,600 $3.28 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $295,152 - $545,688	7,800 Added 159.18%	12,700 $759,000
Q3 2017 Nov 13, 2017	BUY	$37.05 - $47.12 $181,545 - $230,888	4,900	4,900 $231,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.